Analyst Recommendations
Jefferies analyst issues BUY recommendation for FINMY on July 9, 2026 11:37PM ET. The previous analyst recommendation was Hold.FINMY was trading at $29.86 at issue of the analyst...July 9, 2026 FINMY 1.89%
Bernstein analyst issues OUTPERFORM recommendation for JBHT on July 9, 2026 10:38PM ET. The previous analyst recommendation was Market Perform.JBHT was trading at $282.61 at issue of the...July 9, 2026 JBHT -0.61%
Goldman Sachs analyst issues BUY recommendation for AZN on July 9, 2026 08:14PM ET. The previous analyst recommendation was Buy.AZN was trading at $178.49 at issue of the...July 9, 2026 AZN -0.47%
KeyBanc analyst issues SECTOR WEIGHT recommendation for AZN on July 9, 2026 08:14PM ET. AZN was trading at $178.49 at issue of the analyst recommendation.The overall analyst consensus...July 9, 2026 AZN -0.47%
Goldman Sachs analyst issues BUY recommendation for AZN on July 9, 2026 08:14PM ET. The previous analyst recommendation was Buy.AZN was trading at $178.49 at issue of the...July 9, 2026 AZN -0.47%
Goldman Sachs analyst issues BUY recommendation for AZN on July 9, 2026 08:14PM ET. The previous analyst recommendation was Buy.AZN was trading at $178.49 at issue of the...July 9, 2026 AZN -0.47%
Raymond James analyst issues OUTPERFORM recommendation for BTSG on July 9, 2026 08:06PM ET. BTSG was trading at $71.58 at issue of the analyst recommendation.The overall analyst consensus...July 9, 2026 BTSG -1.48%
KeyBanc analyst issues SECTOR WEIGHT recommendation for AZN on July 9, 2026 08:14PM ET. AZN was trading at $178.49 at issue of the analyst recommendation.The overall analyst consensus...July 9, 2026 AZN -0.47%
Deutsche Bank analyst issues BUY recommendation for ING on July 9, 2026 07:33PM ET. The previous analyst recommendation was Buy.ING was trading at $32.495 at issue of the...July 9, 2026 ING -2.75%
Deutsche Bank analyst issues HOLD recommendation for GSK on July 9, 2026 07:33PM ET. The previous analyst recommendation was Hold.GSK was trading at $52.48 at issue of the...July 9, 2026 GSK -0.06%